Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus

Journal of Molecular Recognition

Volumn 24, Issue 6, 2011, Pages 960-974

  Bezuglova, Anna M ^a   Konenkova, Ludmila P ^b   Doronin, Boris M ^c   Buneva, Valentina N ^a,d   Nevinsky, Georgy A ^a,d  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^c NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^d NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

catalytic IgG; human blood; hydrolysis of myelin basic protein; multiple sclerosis; SLE

Indexed keywords

CATALYTIC ANTIBODY; IMMUNOGLOBULIN G; MBP PROTEIN, HUMAN; METAL; MYELIN BASIC PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CATALYSIS; CHEMISTRY; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; KINETICS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBER; PROTEIN DEGRADATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, CATALYTIC; AXONS; CATALYSIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; KINETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METALS; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PROTEOLYSIS;

EID: 80155178879     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1143     Document Type: Article

References (70)

1. Andrievskaia OA, Kanyshkova TG, Iamkovoi VI, Buneva VN, Nevinskii GA,. 1997. Monoclonal antibodies to DNA hydrolyze RNA better than DNA. Dokl. Akad. Nauk 355: 401-403. (Pubitemid 127785456)
2. Andrievskaya OA, Buneva VN, Naumov VA, Nevinsky GA,. 2000. Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit. 6: 460-470. (Pubitemid 30432128)
3. Andrievskaya OA, Buneva VN, Baranovskii AG, Gal'vita AV, Benzo ES, Naumov VA, Nevinsky GA,. 2002. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol. Lett. 81: 191-198. (Pubitemid 34310224)
4. Archelos JJ, Storch MK, Hartung HP,. 2000. The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47: 694-706. (Pubitemid 30390190)
5. Avalle B, Zanin V, Thomas D, Friboulet A,. 1998a. Antibody catalysis based on functional mimicry. Appl. Biochem. Biotechnol. 75: 3-12. (Pubitemid 29168614)
6. Avalle B, Friboulet A, Thomas D,. 1998b. Screening of inhibitory monoclonal antibodies. A critical step for producing anti-idiotypic catalytic antibodies. Ann. NY Acad. Sci. 864: 118-130. (Pubitemid 29048102)
7. Baranova SV, Buneva VN, Kharitonova MA, Sizyakina LP, Calmels C, Andreola ML, Parissi V, Nevinsky GA,. 2009. HIV-1 integrase-hydrolyzing antibodies from sera of HIV-infected patients. Biochimie 91: 1081-1086.
8. Baranova SV, Buneva VN, Kharitonova MA, Sizyakina LP, Calmels C, Andreola ML, Parissi V, Zakharova OD, Nevinsky GA,. 2010. HIV-1 integrase-hydrolyzing IgM antibodies from sera of HIV-infected patients. Int. Immunol. 22: 671-680.
9. Baranovskii AG, Kanyshkova TG, Mogelnitskii AS, Naumov VA, Buneva VN, Gusev EI, Boiko AN, Zargarova TA, Favorova OO, Nevinsky GA,. 1998. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Moscow) 63: 1239-1248. (Pubitemid 128585494)
10. Baranovskii AG, Ershova NA, Buneva VN, Kanyshkova TG, Mogelnitskii AS, Doronin BM, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA,. 2001. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol. Lett. 76: 163-167. (Pubitemid 32295936)
11. Belogurov AA, Kurkova IN, Friboulet A, Thomas D, Misikov VK, Zakharova M. Y, Suchkov SV, Kotov SV, Alehin AI, Avalle B, Suslova EA, Morse 3rd HC, Gabibov AG, Ponomarenko NA,. 2008. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J. Immunol. 180: 1258-1267.
12. Cross AH, Trotter JL, Lyons J,. 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112: 1-14.
13. Debat H, Avalle B, Chose O, Sarde C-O, Friboulet A, Thomas D,. 2001. Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases. FASEB J. 15: 815-822. (Pubitemid 32246000)
14. Dhaunsi GS, Gulati S, Singh AK, Orak JK, Asayama K, Singh I,. 1992. Demonstration of Cu-Zn superoxide dismutase in rat liver peroxisomes. Biochemical and immunochemical evidence. J. Biol. Chem. 267: 6870-6873.
15. Fersht A,. 1985. Enzyme Structure and Mechanism. 2nd ed. W. H. Freeman, Co.: New York.
16. Fontecilla-Camps JC, Volbeda A, Cavazza C, Nicolet Y,. 2007. Structure/function relationships of [NiFe]-and [FeFe]-hydrogenases. Chem. Rev. 107: 4273-4303.
17. Founel S, Muller S,. 2002. Antinucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann. Med. Interne (Paris) 153: 513-519. (Pubitemid 36133227)
18. Friboulet A, Izadyar L, Avalle B, Roseto A, Thomas D,. 1994. Abzyme generation using an anti-idiotypic antibody as the " internal image" of an enzyme active site. Appl. Biochem. Biotechnol. 47: 229-237.
19. Hemmer B, Archelos JJ, Hartung HP,. 2002. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3: 291-301. (Pubitemid 135706608)
20. Hhachn BCh,. 1996. Systemic lupus erythematosus. In Internal diseases., EE Braunvald, KD Isselbakher, RG Petersdorf, DD Wilson, DB Martin, AS Fauchi, (eds). Medicine: Moscow; 407-419.
21. Hu R, Xie GY, Zhang X, Guo ZQ, Jin S,. 1998. Production and characterization of monoclonal anti-idiotypic antibody exhibiting a catalytic activity similar to carboxypeptidase A. J. Biotechnol. 61: 109-115. (Pubitemid 28269320)
22. Ikhmyangan EN, Vasilenko NL, Buneva VN, Nevinsky GA,. 2006. Metal ions-dependent peroxidase and oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats. J. Mol. Recognit. 19: 91-105. (Pubitemid 43374166)
23. Izadyar L, Friboulet A, Remy MH, Roseto A, Thomas D,. 1993. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc. Natl Acad. Sci. U. S. A. 90: 8876-8880. (Pubitemid 23306413)
24. Kalaga R, Li L, O'Dell JR, Paul S,. 1995. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155: 2695-2702.
25. Keinan EE, (ed). 2005. Catalytic antibodies. Wiley-VCH Verlag GmbH & Co. KgaA: Weinheim; 1-586.
26. Kolesnikov AV, Kozyr AV, Alexandrova ES, Koralewski F, Demin AV, Titov MI, Avalle B, Tramontano A, Paul S, Thomas D, Gabibov AG, Friboulet A,. 2000. Enzyme mimicry by the antiidiotypic antibody approach. Proc. Natl Acad. Sci. U. S. A. 97: 13526-13531.
27. Kozyr AV, Kolesnikov A, Aleksandrova ES, Sashchenko LP, Gnuchev NV, Favorov PV, Kotelnikov MA, Iakhina EI, Aatsaturov IA, Prokaeva TB, Alekbarova ZS, Suchkov SV, Gabibov AG,. 1998. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol. 75: 45-61. (Pubitemid 29168618)
28. Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsly GA,. 2007. Activation of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice by different metal ions. Biochim. Biophys. Acta 1774: 884-896. (Pubitemid 46977842)
29. Lacroix-Desmazes S, Moreau A, Sooryanarayana, Bonnemain C, Stieltjes N, Pashov A, Sultan Y, Hoebeke J, Kazatchkine MD, Kaveri SV,. 1999. Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat. Med. 5, 1044-1047. (Pubitemid 29439576)
30. Lacroix-Desmazes S, Bayry J, Kaveri S,., Hayon-Sonsino D, Thorenoor N, Charpentier J, Luyt CE, Mira JP, Nagaraja V, Kazatchkine MD, Dhainaut JF, Mallet VO,. 2005. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc. Natl Acad. Sci. U. S. A. 102: 4109-4113. (Pubitemid 40388563)
31. Legostaeva GA, Polosukhina DI, Bezuglova AM, Doronin BM, Buneva VN, Nevinsky GA,. 2010. Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis. J. Cell. Mol. Med. 14: 699-709.
32. Magorivska IB, Bilyy RO, Havrylyuk AM, Chop'yak VV, Stoika RS, Kit YY,. 2010. Anti-histone H1 IgGs from blood serum of systemic lupus erythematosus patients are capable of hydrolyzing histone H1 and myelin basic protein. J. Mol. Recognit. 23: 495-502
33. Mates JM, Sanchez-Jimenez F,. 1999. Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 4: D339-D345.
34. Neustoev KN, Ivanen DR, sulminskaya AA, Brumer IH, Saveliev AN, Nevinsky GA,. 2003. Amylolytic activity and catalytic properties of IgM and IgG antibodies from patients with systemic lupus erythematosus. Hum. Antibodies 12: 31-34.
35. Nevinsky GA,. 2010. Natural catalytic antibodies in norm and in autoimmune diseases. In Autoimmune Diseases: Symptoms, Diagnosis and Treatment, K.J. Brenner, (ed). Nova Science Publishers, Inc.: Hauppauge, NY 1-107.
36. Nevinsky GA, Buneva VN,. 2002. Human catalytic RNA-and DNA-hydrolyzing antibodies. J. Immunol. Methods 269: 235-249.
37. Nevinsky GA, Buneva VN,. 2003. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med. 7: 265-276. (Pubitemid 37372046)
38. Nevinsky GA, Buneva VN,. 2005. Natural catalytic antibodies-abzymes. In Catalytic antibodies, E Keinan, (ed). VCH-Wiley press; 503-567.
39. Nevinsky GA, Buneva VN,. 2010. Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases. ScientificWorldJournal 10: 1203-1233.
40. Nevinsky GA, Breusov AA, Baranovskii AG, Prints AV, Kanyshkova TG, Galvita AV, Naumov VA, Buneva VN,. 2001. Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Med. Sci. Monit. 7: 201-211. (Pubitemid 32244796)
41. Nevinsky GA, Favorova OO, Buneva VN,. 2002. Catalytic Antibodies: New Characters in the Protein Repertoire. Protein-Protein Interactions. A Molecular Cloning Manual. Cold Spring Harbor: NY; 523-534.
42. O'Connor KC, Bar-Or A, Hafler DA,. 2001. Neuroimmunology of multiple sclerosis. J. Clin. Immunol. 21: 81-92.
43. Odintsova ES, Buneva VN, Nevinsky GA,. 2005. Casein-hydrolyzing activity of sIgA antibodies from human milk. J. Mol. Recognit. 18: 413-421. (Pubitemid 41336795)
44. Odintsova ES,., Kharitonova MA, Baranovskii AG, Siziakina LP, Buneva VN, Nevinsky GA,. 2006. Proteolytic activity of IgG antibodies from blood of acquired immunodeficiency syndromepatients. Biochemistry (Moscow) 71: 251-261.
45. Odintsova ES, Zaksas NP, Buneva VN, Nevinsky GA,. 2010. Metal dependent hydrolysis of β-casein by sIgA antibodies from human milk. J. Mol. Recogn. 2011 Jan; 24 (1): 45-59.
46. Parkhomenko TA, Buneva VN, Tyshkevich OB, Generalov II, Doronin BM, Nevinsky GA,. 2010a. DNA-hydrolyzing activity of IgG antibodies from the sera of patients with tick-borne encephalitis. Biochimie 92: 545-554.
47. Parkhomenko TA, Legostaeva GA, Doronin BM, Buneva VN, Nevinsky GA,. 2010b. IgGs containing light chains of the λ and κ type and of all subclasses (IgG1-IgG4) from sera of patients with multiple sclerosis hydrolyze DNA. J. Mol. Recognit. 23: 486-494.
48. Paul S,. 1998. Mechanism and functional role of antibody catalysis. Appl. Biochem. Biotechnol. 75: 13-23.
49. Paul S, Volle DJ, Beach CM, Johnson DR, Powell MJ, Massey RJ,. 1989. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244: 1158-1162. (Pubitemid 19170484)
50. Paul S, Li L, Kalaga R, Wilkins-Stevens P, Stevens FJ, Solomon A,. 1995. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and V fragment. J. Biol. Chem. 270: 15257-15261.
51. Pisetsky D,. 2001. Immune response to DNA in systemic lupus erythematosus. Isr. Med. Ass. J. 3: 850-853. (Pubitemid 34082787)
52. Polosukhina DI, Kanyshkova T, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA,. 2004. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell. Mol. Med. 8: 359-368. (Pubitemid 44145499)
53. Polosukhina DI, Buneva VN, Doronin BM, Tyshkevich OB, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA,. 2005. Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. Med. Sci. Monit. 11: BR266-BR 272.
54. Polosukhina DI, Kanyshkova TG, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA,. 2006. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol. Lett. 103: 75-81. (Pubitemid 43162949)
55. Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA, Kurkova IN, Petrenko AG, Telegin GB, Suchkov SV, Kiselev SL, Lagarkova MA, Govorun VM, Serebryakova MV, Avalle B, Tornatore P, Karavanov A, Thomas D, Friboulet A, Gabibov AG,. 2006. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl Acad. Sci. U. S. A. 103: 281-286. (Pubitemid 43122392)
56. Poser CM,. 1984. The Diagnosis of Multiple Sclerosis. Thieme-Stratton: NY; 3-13.
57. Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T,. 1999. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122: 2047-2056.
58. Savel'ev AN, Kulminskaya AA, Ivanen DR, Nevinsky GA, Neustroev KN,. 2004. Human antibodies with amylolytic activity. Trends Glycosci. Glyc. 16: 17-31.
59. Saveliev AN, Ivanen DR, Kulminskaya AA, Ershova NA, Kanyshkova TG, Buneva VN, Mogelnitskii AS, Doronin BM, Favorova OO, Nevinsky GA, Neustroev KN,. 2003. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett. 86: 291-297. (Pubitemid 36428690)
60. Shelpakova IR, Zaksas NP, Komissarova LN, Kovalevskij SV,. 2002. Spectral methods for analysis of high-purity gallium with excitation of spectra in the two-jet arc plasmatron. J. Anal. At. Spectrom. 17: 270-273. (Pubitemid 34476538)
61. Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG,. 1992. DNA hydrolyzing autoantibodies. Science 256: 665-667.
62. Sinohara H, Matsuura K,. 2000. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma. Appl. Biochem. Biotechnol. 83: 85-94.
63. Terryberry JW, Thor G, Peter JB,. 1998. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol. Aging 19: 205-216. (Pubitemid 28331297)
64. Thiagarajan P, Dannenbring R, Matsuura K, Tramontano A, Gololobov G, Paul S,. 2000. Monoclonal antibody light chain with prothrombinase activity. Biochemistry 39: 6459-6465. (Pubitemid 30347151)
65. Tolmacheva AS, Zaksas NP, Buneva VN, Vasilenko NL, Nevinsky GA,. 2009. Oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats are better activated by combinations of different metal ions. J. Mol. Recognit. 22: 26-37
66. Tyutyulkova S, Gao QS, Thompson A, Rennard S, Paul S,. 1996. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display. Biochim. Biophys. Acta 1316: 217-223. (Pubitemid 26273707)
67. Williamson RA, Burgoon MP, Owens GP, Ghausi O, Leclerc E, Firme L, Carlson S, Corboy J, Parren PW, Sanna PP, Gilden DH, Burton DR,. 2001. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl Acad. Sci. U. S. A. 98: 1793-1798. (Pubitemid 32165577)
68. Zaksas NP, Sultangazieva TT, Korda TM,. 2006. Using a two-jet plasmatron for determining the trace element composition of powdered biological samples. J. Anal. Chem. 61: 582-587. (Pubitemid 43855926)
69. Zaksas N.P., Sultangazieva T.T., Gerasimov V.A,. 2008. Determination of trace elements in bone by two-jet plasma atomic emission spectrometry. Anal. Bioanal. Chem. 391: 687-693.
70. Zenkov NK, Lankin VZ, Men'shikova E.B,. 2001. Oxidative Stress. Biochemical and Pathophysiological Aspects. MAIK, Nauka/Interperiodica: Moscow; 3-343.